Brigham And Women's Hospital in Boston, Massachusetts - Dialysis Center

Brigham And Women's Hospital is a medicare approved dialysis facility center in Boston, Massachusetts and it has 7 dialysis stations. It is located in Suffolk county at Dialysis Unit, Boston, MA, 02115. You can reach out to the office of Brigham And Women's Hospital at (617) 732-6130. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Brigham And Women's Hospital has the following ownership type - Non-Profit. It was first certified by medicare in August, 1977. The medicare id for this facility is 220110 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBrigham And Women's Hospital
LocationDialysis Unit, Boston, Massachusetts
No. of Dialysis Stations 7
Medicare ID220110
Managed ByIndependent
Ownership TypeNon-Profit
Late Shifts No

Contact Information


Dialysis Unit, Boston, Massachusetts, 02115
(617) 732-6130
Not Available

News Archive

Sunscreens containing nanoparticles alarms consumer group

The consumer group CHOICE is demanding more honesty from sunscreen manufacturers after many leading brands were found to contain nanoparticles. There is controversy as to whether the particles, which are smaller than 100 billionths of a meter, can penetrate the skin and have harmful side-effects, says CHOICE. However many of these sunscreens contain nano-grade titanium dioxide and zinc oxide that enable them to offer the same sun protection but go on clear and with less skin residue.

ACG offers updated clinical guidance for managing pregnant patients

Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.

Computational model can help identify best allocation plans for distributing test kits

Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy.

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

Read more Medical News

› Verified 6 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Brigham And Women's Hospital from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Patient Distribution

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center8
    Adult patient months included in Kt/V greater than or equal to 1.233
    Percentage of adult patients getting regular hemodialysis at the center
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Sunscreens containing nanoparticles alarms consumer group

    The consumer group CHOICE is demanding more honesty from sunscreen manufacturers after many leading brands were found to contain nanoparticles. There is controversy as to whether the particles, which are smaller than 100 billionths of a meter, can penetrate the skin and have harmful side-effects, says CHOICE. However many of these sunscreens contain nano-grade titanium dioxide and zinc oxide that enable them to offer the same sun protection but go on clear and with less skin residue.

    ACG offers updated clinical guidance for managing pregnant patients

    Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.

    Computational model can help identify best allocation plans for distributing test kits

    Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy.

    Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

    Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

    Read more Medical News

    › Verified 6 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Brigham And Women's Hospital with elevated calcium levels.

Patients with hypercalcemia13
Hypercalcemia patient months77
Hypercalcemia patients with serumcalcium greater than 10.2 mg4
Patients with Serumphosphor8
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

News Archive

Sunscreens containing nanoparticles alarms consumer group

The consumer group CHOICE is demanding more honesty from sunscreen manufacturers after many leading brands were found to contain nanoparticles. There is controversy as to whether the particles, which are smaller than 100 billionths of a meter, can penetrate the skin and have harmful side-effects, says CHOICE. However many of these sunscreens contain nano-grade titanium dioxide and zinc oxide that enable them to offer the same sun protection but go on clear and with less skin residue.

ACG offers updated clinical guidance for managing pregnant patients

Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.

Computational model can help identify best allocation plans for distributing test kits

Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy.

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

Read more Medical News

› Verified 6 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 21
Patient months included in arterial venous fistula and catheter summaries 32
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment56
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer3

News Archive

Sunscreens containing nanoparticles alarms consumer group

The consumer group CHOICE is demanding more honesty from sunscreen manufacturers after many leading brands were found to contain nanoparticles. There is controversy as to whether the particles, which are smaller than 100 billionths of a meter, can penetrate the skin and have harmful side-effects, says CHOICE. However many of these sunscreens contain nano-grade titanium dioxide and zinc oxide that enable them to offer the same sun protection but go on clear and with less skin residue.

ACG offers updated clinical guidance for managing pregnant patients

Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.

Computational model can help identify best allocation plans for distributing test kits

Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy.

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

Read more Medical News

› Verified 6 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary4
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

News Archive

Sunscreens containing nanoparticles alarms consumer group

The consumer group CHOICE is demanding more honesty from sunscreen manufacturers after many leading brands were found to contain nanoparticles. There is controversy as to whether the particles, which are smaller than 100 billionths of a meter, can penetrate the skin and have harmful side-effects, says CHOICE. However many of these sunscreens contain nano-grade titanium dioxide and zinc oxide that enable them to offer the same sun protection but go on clear and with less skin residue.

ACG offers updated clinical guidance for managing pregnant patients

Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.

Computational model can help identify best allocation plans for distributing test kits

Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy.

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

Read more Medical News

› Verified 6 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Brigham And Women's Hospital were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility25.7 (As Expected)
Readmission Rate: Upper Confidence Limit38.6
Readmission Rate: Lower Confidence Limit14.5

News Archive

Sunscreens containing nanoparticles alarms consumer group

The consumer group CHOICE is demanding more honesty from sunscreen manufacturers after many leading brands were found to contain nanoparticles. There is controversy as to whether the particles, which are smaller than 100 billionths of a meter, can penetrate the skin and have harmful side-effects, says CHOICE. However many of these sunscreens contain nano-grade titanium dioxide and zinc oxide that enable them to offer the same sun protection but go on clear and with less skin residue.

ACG offers updated clinical guidance for managing pregnant patients

Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.

Computational model can help identify best allocation plans for distributing test kits

Getting accurate, timely information on COVID-19 cases is one of the major challenges facing policymakers as they make decisions about public health and the economy.

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

Read more Medical News

› Verified 6 days ago